BOPI 07 BR/2023 REPERTOIRE NUMERIQUE 40 2-CODAGENIX INC., 3 Bioscience Park Drive, FARMINGDALE, New York 11735-0176 (US) (74) Cabinet BONNY & ASSOCIÉS, LAW FIRM, B.P. 35349, YAOUNDE (CM). (57) The present disclosure describes deoptimized foot and mouth viruses and their use for prophylactic and therapeutic treatment of mammalian subjects. The recombinant viruses provided herein include alterations in several genomic regions as well as Differentiating Infected from Vaccinated Animals (DIVA) markers. Fig. 12 Consulter le mémoire ________________________________________ (11) 21073 (51) C09D 5/00 (2018.01) ; C09K 3/22 (2018.01) (21) 1202200501 - PCT/EP2021/063459 (22) 20/05/2021 (30) EP n° 20176894.2 du 27/05/2020 (54) Biocementation mixture for dust control and related applications. (72) Martin SPITZNAGEL (DE); Luitpold FRIED (DE); Saskia PAZUR (DE); Jan-Philip MERKL (DE) et Florian HORNUNG (DE) (73) BIND-X GMBH, Am Klopferspitz 19, PLANEGG 82152 (DE) (74) Cabinet ISIS CONSEILS (SCP), Bastos, rue 1.862, face de l'Agence Turque de Coopération et de Coordination, B.P. 15067, YAOUNDE (CM). (57) The present invention relates primarily to the use of a mixture for reducing dust formation and/or erosion. The invention relates additionally to a method for reducing dust formation and/or erosion and also to a mixture suitable for this purpose. Fig. 8 Consulter le mémoire
RkJQdWJsaXNoZXIy MTM1NDc3MA==